LINTEX
920106
LINGOOD
833284
NTGEC
870436
4
CG MED EQUIP.
838810
5
Jiayu Holding
300117
CN Stock MarketDetailed Quotes
002653 Haisco Pharmaceutical Group
- 33.31
- -1.10-3.20%
Market Closed Feb 28 15:00 CST
37.30BMarket Cap78.38P/E (TTM)
34.80High33.15Low52.76KlotVolume34.00Open34.41Pre Close177.93MTurnover0.99%Turnover Ratio126.17P/E (Static)1.12BShares40.5352wk High9.23P/B17.85BFloat Cap23.8452wk Low37.85Limit Up535.83MShs Float40.53Historical High30.97Limit Down4.80%Amplitude2.90Historical Low0.48Dividend TTM33.72Avg Price25.44KlotAsk1.44%Div YieldTTM100Lot Size23.67KlotBid
Haisco Pharmaceutical Group News
HiCisco: Announcement of Resolutions of the 13th Meeting of the Fifth Board of Supervisors
HiCisco: Verification Report on the Use of Funds Raised by Hisicus Pharmaceuticals Group Co., Ltd. for the period ending January 31, 2025
HiCisco: Announcement on regulatory measures or penalties and rectification by securities regulators and exchanges in the last five years
HiCisco: Special Report on the Use of Previously Raised Funds
HiCisco: Announcement of Resolutions of the 24th Meeting of the Fifth Board of Directors
HiCisco: Announcement of Resolutions of the 23rd Meeting of the Fifth Board of Directors
HiCisco: Announcement on Obtaining the “Drug Clinical Trial Approval Notice” for the innovative drug HSK39004 inhalation powder
HiCisco: Announcement on the signing of a tripartite supervisory agreement on fund-raising
HiCisco: Huatai United Securities Co., Ltd.\'s inspection opinion on the use of idle funds raised by Hisilicon Pharmaceuticals Group Co., Ltd. for cash management
HiCisco: Announcement of Resolutions of the 22nd Meeting of the Fifth Board of Directors
HiCisco: Announcement on Obtaining the “Drug Clinical Trial Approval Notice” for the New Indication of the Innovative Drug HSK44459 Tablets
HiCisco: Announcement on Using Idle Raised Funds for Cash Management
HiCisco: Announcement of Resolutions of the 12th Meeting of the Fifth Board of Supervisors
HiCisco: Huatai United Securities Co., Ltd. report on the 2024 continuous supervision and training of Hisilicon Pharmaceuticals Group Co., Ltd.
HiCisco: Huatai United Securities Co., Ltd. site inspection report on Hisilicon Pharmaceuticals Group Co., Ltd.\'s 2024 continuous supervision work site
HiCisco: Opinions of Huatai United Securities Co., Ltd. on the overall completion of the fund-raising investment project of Hisicus Pharmaceuticals Group Co., Ltd. and follow-up arrangements for fund savings
HiCisco: Independent Directors\' Review Opinions on Matters Related to the 21st Meeting of the Fifth Board of Directors
HiCisco: Announcement of Resolutions of the 21st Meeting of the Fifth Board of Directors
HiCisco: Announcement of Resolutions of the 11th Meeting of the Fifth Board of Supervisors
HiCisco: Announcement on the return of all idle raised funds to temporarily supplement working capital